Brief: Episurf Medical Says Episealer® Patellofemoral System Under Substantive Review At The US FDA
24/04/2022 20:05
April 24 (Reuters) - Episurf Medical AB EPISb.ST :
* EPISURF MEDICAL'S EPISEALER® PATELLOFEMORAL SYSTEM UNDER
SUBSTANTIVE REVIEW AT THE US FDA
* EPISURF MEDICAL AB - WILL CONTINUE PREPARATIONS FOR A US
MARKET
LAUNCH WHILE APPLICATION IS UNDERGOING REVIEW
Source text for Eikon: ID:nWkr6LJWfs
Further company coverage: EPISb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Episurf Medical AB
See all newsBrief: Futur Pension Holding Increases Stake In Episurf Medical
Brief: Episurf Board To Propose Transaction Approval
Brief: Mofast Divests Major Shareholding In Episurf, To Increase Holding
Brief: Episurf Medical Enters Into LoI Regarding Acquisition Of Property
Brief: Episurf Medical Signs Property Management Agreement With Newsec